Thomas Marjot

Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: An international registry study

Thomas Marjot, Andrew M. Moon, Jonathan Cook et al. · Journal of Hepatology · 2020 · 525 citations · Full text

Medicine, Immunology, Infectious Diseases +17

FXR inhibition may protect from SARS-CoV-2 infection by reducing ACE2

Teresa Brevini, Mailis Maes, Gwilym J. Webb et al. · Nature · 2022 · 294 citations · Full text

Medicine, Infectious Diseases, Pharmacology +13

Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry study

Gwilym J. Webb, Thomas Marjot, Jonathan Cook et al. · ˜The œLancet. Gastroenterology & hepatology · 2020 · 235 citations · Full text

Medicine, Infectious Diseases, Surgery +16

Two doses of SARS-CoV-2 vaccination induce robust immune responses to emerging SARS-CoV-2 variants of concern

Donal Skelly, Adam Harding, Javier Gilbert‐Jaramillo et al. · Nature Communications · 2021 · 191 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +16

SARS-CoV-2-specific immune responses and clinical outcomes after COVID-19 vaccination in patients with immune-suppressive disease

Eleanor Barnes, Carl S. Goodyear, Michelle Willicombe et al. · Nature Medicine · 2023 · 133 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17